Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease.
Zingone A, Wang W, Corrigan-Cummins M, Wu SP, Plyler R, Korde N, Kwok M, Manasanch EE, Tageja N, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Roschewski M, Zhang Y, Roccaro AM, Ghobrial IM, Calvo KR, Landgren O. Zingone A, et al. Among authors: yancey ma. Cytokine. 2014 Oct;69(2):294-7. doi: 10.1016/j.cyto.2014.05.017. Epub 2014 Jul 17. Cytokine. 2014. PMID: 25043675 Free PMC article.
A case study progression to multiple myeloma.
Yancey MA, Waxman AJ, Landgren O. Yancey MA, et al. Clin J Oncol Nurs. 2010 Aug;14(4):419-22. doi: 10.1188/10.CJON.419-422. Clin J Oncol Nurs. 2010. PMID: 20682498 Free PMC article.
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study.
Cherry BM, Korde N, Kwok M, Manasanch EE, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Maric I, Calvo KR, Braylan R, Stetler-Stevenson M, Yuan C, Tembhare P, Zingone A, Costello R, Roschewski MJ, Landgren O. Cherry BM, et al. Among authors: yancey ma. Leuk Lymphoma. 2013 Oct;54(10):2215-8. doi: 10.3109/10428194.2013.764419. Epub 2013 Jul 29. Leuk Lymphoma. 2013. PMID: 23311294 Free PMC article.
Oncology drug development: what is changing?
Yancey MA. Yancey MA. Clin J Oncol Nurs. 2008 Oct;12(5):713-5. doi: 10.1188/08.CJON.713-715. Clin J Oncol Nurs. 2008. PMID: 18842527 No abstract available.
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies.
Kummar S, Gutierrez ME, Gardner ER, Chen X, Figg WD, Zajac-Kaye M, Chen M, Steinberg SM, Muir CA, Yancey MA, Horneffer YR, Juwara L, Melillo G, Ivy SP, Merino M, Neckers L, Steeg PS, Conley BA, Giaccone G, Doroshow JH, Murgo AJ. Kummar S, et al. Among authors: yancey ma. Eur J Cancer. 2010 Jan;46(2):340-7. doi: 10.1016/j.ejca.2009.10.026. Epub 2009 Nov 27. Eur J Cancer. 2010. PMID: 19945858 Free PMC article. Clinical Trial.